BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15086196)

  • 21. Controversies in the use of portal vein embolization.
    van Gulik TM; van den Esschert JW; de Graaf W; van Lienden KP; Busch OR; Heger M; van Delden OM; Laméris JS; Gouma DJ
    Dig Surg; 2008; 25(6):436-44. PubMed ID: 19212116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type IV collagen 7s domain as a predictor of poor efficacy of portal vein embolization before major hepatectomy.
    Wu JS; Kubo S; Tanaka H; Shuto T; Takemura S; Tsukamoto T; Hirohashi K; Kinoshita H
    Surg Today; 2005; 35(1):41-6. PubMed ID: 15622463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in clinicopathological findings after portal vein embolization.
    Fujii Y; Shimada H; Endo I; Kamiyama M; Kamimukai N; Tanaka K; Kunisaki C; Sekido H; Togo S; Nagashima Y
    Hepatogastroenterology; 2000; 47(36):1560-3. PubMed ID: 11149001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperbaric oxygenation after portal vein emobilization for regeneration of the predicted remnant liver.
    Uwagawa T; Unemura Y; Yamazaki Y
    J Surg Res; 2001 Sep; 100(1):63-8. PubMed ID: 11516206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative portal vein embolization for liver malignancies.
    Tarazov PG; Granov DA; Sergeev VI; Polikarpov AA; Polysalov VN; Rozengauz EV
    Hepatogastroenterology; 2006; 53(70):566-70. PubMed ID: 16995463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective portal vein embolization with absolute ethanol induces hepatic hypertrophy and makes more extensive hepatectomy possible.
    Ogasawara K; Uchino J; Une Y; Fujioka Y
    Hepatology; 1996 Feb; 23(2):338-45. PubMed ID: 8591861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Portal serum human hepatocyte growth factor levels after partial hepatectomy.
    Higaki I; Yamazaki O; Matsuyama M; Horii K; Kawai S; Hirohashi K; Kinoshita H
    Hepatogastroenterology; 1999; 46(26):1078-82. PubMed ID: 10370670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of portal vein embolization before right hepatectomy.
    Nanashima A; Sumida Y; Abo T; Nonaka T; Takeshita H; Hidaka S; Sawai T; Yasutake T; Sakamoto I; Nagayasu T
    Hepatogastroenterology; 2009; 56(91-92):773-7. PubMed ID: 19621700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Percutaneous transhepatic portal vein embolization for hepatocellular carcinoma].
    Tanaka H; Kinoshita H; Hirohashi K; Yamasaki O; Kubo S; Tsukamoto T; Hamba H; Shuto T; Morimoto Y; Mikami S
    Nihon Geka Gakkai Zasshi; 1998 Apr; 99(4):234-40. PubMed ID: 9642692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced inflammatory cytokine production at ischemia/reperfusion in human liver resection.
    Kim YI; Song KE; Ryeon HK; Hwang YJ; Yun YK; Lee JW; Chun BY
    Hepatogastroenterology; 2002; 49(46):1077-82. PubMed ID: 12143206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.
    Elias D; Santoro R; Ouellet JF; Osmak L; de Baere T; Roche A
    Hepatogastroenterology; 2004; 51(60):1788-91. PubMed ID: 15532827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical studies of new material for portal vein embolization: comparison of embolic effect with different agents.
    Kaneko T; Nakao A; Takagi H
    Hepatogastroenterology; 2002; 49(44):472-7. PubMed ID: 11995476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum interleukin-6 and hepatocyte growth factor levels in patients after hepatectomy.
    Chijiiwa K; Saiki S; Tanaka M
    Hepatogastroenterology; 2002; 49(44):467-71. PubMed ID: 11995475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases.
    Pamecha V; Glantzounis G; Davies N; Fusai G; Sharma D; Davidson B
    Ann Surg Oncol; 2009 May; 16(5):1202-7. PubMed ID: 19130138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience.
    Giraudo G; Greget M; Oussoultzoglou E; Rosso E; Bachellier P; Jaeck D
    Surgery; 2008 Apr; 143(4):476-82. PubMed ID: 18374044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative portal vein embolization: is it useful?
    Takayama T; Makuuchi M
    J Hepatobiliary Pancreat Surg; 2004; 11(1):17-20. PubMed ID: 15747030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portal embolization in various types of liver: novel variables to predict hypertrophy.
    Kaido T; Arii S; Shimada Y; Mori A; Imamura M
    Hepatogastroenterology; 2003; 50(49):140-5. PubMed ID: 12630010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome.
    Abdalla EK
    J Surg Oncol; 2010 Dec; 102(8):960-7. PubMed ID: 21165999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative portal vein embolization for major liver resection: a meta-analysis.
    Abulkhir A; Limongelli P; Healey AJ; Damrah O; Tait P; Jackson J; Habib N; Jiao LR
    Ann Surg; 2008 Jan; 247(1):49-57. PubMed ID: 18156923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.